Mary Beckerle sold company stock of Exelixis, Inc. under a trading plan.
1 report, 1 independent
Updated Aug 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Mary Beckerle sold company stock of Exelixis, Inc. under a trading plan.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Mary Beckerle
American biologist and businessperson, CEO of Huntsman Cancer Institute at the University of Utah and corporate director at Johnson and Johnson